keyword
MENU ▼
Read by QxMD icon Read
search

haemopoietic stem cell transplant leukaemia aplastic anaemia

keyword
https://www.readbyqxmd.com/read/11919737/leukaemic-transformation-of-donor-cells-in-a-patient-receiving-a-second-allogeneic-bone-marrow-transplant-for-severe-aplastic-anaemia
#1
REVIEW
M Lawler, A Locasciulli, D Longoni, R Schiro, S R McCann
Allogeneic blood or bone marrow transplantation is a successful treatment for leukaemia and severe aplastic anaemia (SAA). Graft rejection following transplantation for leukaemia is a rare event but leukaemic relapse may occur at varying rates, depending upon the stage of leukaemia at which the transplant was undertaken and the type of leukaemia. Relapse is generally assumed to occur in residual host cells, which are refractory to, or escape from the myeloablative conditioning therapy. Rare cases have been described, however, in which the leukaemia recurs in cells of donor origin...
March 2002: Bone Marrow Transplantation
https://www.readbyqxmd.com/read/10221503/clonal-evolution-of-aplastic-anaemia-to-myelodysplasia-acute-myeloid-leukaemia-and-paroxysmal-nocturnal-haemoglobinuria
#2
REVIEW
J A Tooze, J C Marsh, E C Gordon-Smith
Aplastic anaemia (AA) is a non-malignant haemopoietic disorder characterised by peripheral blood pancytopenia and a hypocellular bone marrow. Successful management of acquired AA including treatment with immunosuppressive agents, mainly antithymocyte globulin (ATG) and cyclosporin or allogeneic haemopoietic stem cell transplantation, has resulted in long-term survival of many patients. The later evolution of complicating clonal disorders such as paroxysmal nocturnal haemoglobinuria, myelodysplasia and acute myeloid leukaemia in patients treated with immunosuppressive therapy may be a manifestation of the natural history of the aplasia, the development of which may or may not be increased by immunosuppressive therapy...
April 1999: Leukemia & Lymphoma
https://www.readbyqxmd.com/read/9916638/haemopoietic-cell-transplantation-activity-and-results-a-single-institution-experience
#3
A Barta, A Batai, E Torbagyi, A Sipos, L Lengyel, G G Petranyi, K Paloczi, E Kelemen
Between February 1993 and November 1997, 62 patients with severe aplastic anaemia (SAA), acute myeloid (AML), acute lymphoid (ALL), or chronic myeloid leukaemia (CML) as well as two patients with NHL underwent allogeneic marrow transplantation (BMT) from HLA-identical or one-antigen mismatched sibling or unrelated donors. Patients received preparative regimens according to the baseline disease. Patients with SAA were conditioned with ATG/Cy (2 cases) and TAI/Cy (3 cases), AML, ALL and NHL with TBI/Cy (21 cases including two retransplantations) and CML with Mitobronitol/Ara-C/Cy except two patients conditioned traditionally with Bu/Cy...
December 1998: Bone Marrow Transplantation
https://www.readbyqxmd.com/read/8982051/transplantation-of-peripheral-blood-progenitor-cells-from-hla-identical-sibling-donors-european-group-for-blood-and-marrow-transplantation-ebmt
#4
N Schmitz, A Bacigalupo, M Labopin, I Majolino, J P Laporte, L Brinch, G Cook, G L Deliliers, A Lange, C Rozman, J Garcia-Conde, J Finke, A Domingo-Albos, A Gratwohl
Transplantation of peripheral blood progenitor cells (PBPCs) has largely replaced autologous bone marrow transplantation. The same might occur in the allogeneic setting if the favourable initial experience with allogeneic PBPCT is confirmed. We analysed all primary transplants utilizing unmodified PBPC from HLA-identical sibling donors reported to the European Group for Blood and Marrow Transplantation (EBMT) for 1994. 59 patients with a median age of 39 years received myeloablative therapy for acute myelogenous leukaemia (23 patients, acute lymphoblastic leukaemia (13), chronic myelogenous leukaemia (nine), lymphoma (seven), or other diagnoses (seven) mostly of advanced stages followed by transplantation of allogeneic PBPC...
December 1996: British Journal of Haematology
https://www.readbyqxmd.com/read/8562408/indications-for-haemopoietic-precursor-cell-transplants-in-europe-european-group-for-blood-and-marrow-transplantation-ebmt
#5
MULTICENTER STUDY
A Gratwohl, J Hermans, H Baldomero, A Tichelli, J M Goldman, G Gahrton
Information on 17,206 haemopoietic precursor cell transplants performed in 12 European countries between 1991 and 1993 was used to assess the number of transplants per million inhabitants per year by principal indication and donor source. 16.6 transplants were performed per million inhabitants per year with a range of 9.4-27.7. Differences between countries may be due to the availability of beds and resources or to divergent opinions about treatments. We used the coefficient of variation (CV) to assess the degree of agreement between clinicians with regard to different procedures and indications, with a cut-off of < or = 45% to indicate consensus...
January 1996: British Journal of Haematology
https://www.readbyqxmd.com/read/7023879/environmental-factors-in-haemopoietic-failure-in-humans
#6
REVIEW
E C Gordon-Smith, M Y Gordon
Aplastic anaemia can be defined as pancytopenia in the presence of a hypoplastic bone marrow and in the absence of leukaemia or malignant infiltration. Most cases have been attributed to an intrinsic defect in the pluripotential haemopoietic stem cell; however, stem cell suppression or a defect in the marrow environment would also produce the symptoms of aplasia. In vitro culture systems have been used to explore these possibilities and have provided evidence that the syndrome known as aplastic anaemia includes several distinct disease processes...
1981: Ciba Foundation Symposium
https://www.readbyqxmd.com/read/3302548/chromosomal-analysis-of-bone-marrow-stromal-fibroblasts-in-allogeneic-hla-compatible-sibling-bone-marrow-transplantations
#7
D D Ma, W M Da, S Purvis-Smith, J C Biggs
Karyotyping was performed on bone marrow stromal fibroblasts and marrow haemopoietic cells on six patients who received bone marrow transplants from siblings of the opposite sex. Three patients with severe aplastic anaemia received unmanipulated donor bone marrow cells. Three other patients with leukaemia and conditioned with high dose chemotherapy (+ total body irradiation in two patients) received T-cell depleted marrow mononuclear cells. Marrow chromosomal analysis was performed on samples obtained between 6 weeks and 1 yr post-transplant...
1987: Leukemia Research
https://www.readbyqxmd.com/read/1954987/inhibitory-effect-of-cyclosporin-a-on-erythroid-and-stromal-colonies
#8
E Clarke, D G Quinn, S R McCann
Cyclosporin A is used to prevent graft-versus-host disease (GvHD) following bone marrow transplantation (BMT) and it has been implicated in reducing the time to engraftment for leukaemia and aplastic anaemia patients. To evaluate the effect of cyclosporin A on engraftment, the proliferative capacity of bone marrow progenitors (CFU-E, CFU-F and CFU-C) was assessed both in vitro and following treatment with cyclosporin A over a 9-week period using an animal model. Cyclosporin had a differential effect on the haemopoietic progenitors, with the myeloid series unaffected at therapeutic concentrations...
October 1991: European Journal of Haematology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"